9TH DresDen symposium on AuToAnTiboDies - (GFID) eV
9TH DresDen symposium on AuToAnTiboDies - (GFID) eV 9TH DresDen symposium on AuToAnTiboDies - (GFID) eV
THursDAy sepTember 03 16.00–17.30 MOLECULAR MIMICRY AND AUTOIMMUNE DISEASES Co-Chairs: y. shoenfeld (Tel-Hashomer, israel) A. ebringer (london, uK) 16.00–16.30 molecular mimicry in ankylosing spondylitis and rheumatoid arthritis Alan Ebringer (London, UK) 16.30–17.00 polymyalgia rheumatica, blindness and anti-proteus antibodies Roland Pechlaner (Innsbruck, Austria) 17.00–17.30 * Vaccination and autoimmunity Nancy Agmon-Levin (Tel-Hashomer, Israel) 16.30–18.30 PRESENTATIONS OF YOUNG SCIENTISTS Co-Chairs: K. Conrad (Dresden, germany) u. sack (leipzig, germany) 16.30–16.40 * gender differences in oxidative stress and apoptosis of vascular cells induced by autoantibodies specific to rlip76 Tania Colasanti (Rome, Italy) 16.40-16.50 * immortalized b cell lines from multiple sclerosis patients produce antibodies that bind an oligodendrocyte precursor cell line Judith Fraussen (Diepenbeek, Belgium) 16.50–17.00 * Analysis of autoantibody profiles in cerebrospinal fluid and serum of a relapsing-remitting ms patient with active disease using serological Antigen selection Cindy Govarts (Diepenbeek, Belgium) 10
THursDAy sepTember 03 * Anti-Cenp-A and anti-Cenp-b antibodies show high concordance and similar clinical associations in patients with systemic sclerosis despite completely different underlying protein sequences Katharina Hanke (Potsdam, Germany) * Anti-argonaute2 (Ago2/su) and -ro antibodies are the common autoantibody specificities in primary anti-phospholipid syndrome (pAps) Angela Ceribelli (Brescia, Italy) * ß1-adrenoreceptor autoantibodies in a lewis rat model of dilated cardiomyopathy Vladimir Kocoski (Würzburg, Germany) 17.00–17.10 17.10–17.20 17.20–17.30 * Heterogeneous nuclear ribonucleoproteins, novel target antigens of autoantibodies in autoimmune disease Katrijn Op De Beéck (Leuven, Belgium) * occurrence of autoantibodies to calreticulin in oncological patients and patients from risk groups Aneta Pekáriková (Prague, Czech Republic) 17.30–17.40 17.40–17.50 * Technical parameters of particle array development Kai Großmann (Senftenberg, Germany) * performance evaluation of pr3-AnCA elisAs Matthew Hayman (Christchurch, New Zealand) Discussion 17.50–18.00 18.00–18.10 18.10–18.30 11
- Page 1 and 2: 9 TH DresDen <stro
- Page 3 and 4: WelCome Dear Colleagues, on behalf
- Page 5 and 6: WeDnesDAy sepTember 02 Registration
- Page 7 and 8: THursDAy sepTember 03 PATHOGENETIC
- Page 9: THursDAy sepTember 03 NOVEL AND ESO
- Page 13 and 14: FriDAy sepTember 04 stratification
- Page 15 and 16: FriDAy sepTember 04 DRESDEN PRICE O
- Page 17 and 18: sATurDAy sepTember 05 recombinant i
- Page 19 and 20: Methodical aspects P8 laboratory po
- Page 21 and 22: P20 Clinical relevance of AnCA in r
- Page 23 and 24: P35 Anti-Cenp-A and anti-Cenp-b ant
- Page 25 and 26: P47 Co-incidence of serum anti-gang
- Page 27 and 28: inFormATions WeDnesDAy sepTember 1
- Page 29 and 30: WeDnesDAy inFormATions sepTember 1
- Page 31 and 32: GA Generic Assays GmbH (Dahlewitz,
THursDAy<br />
sepTember 03<br />
16.00–17.30<br />
MOLECULAR MIMICRY<br />
AND AUTOIMMUNE DISEASES<br />
Co-Chairs: y. shoenfeld (Tel-Hashomer, israel)<br />
A. ebringer (l<strong>on</strong>d<strong>on</strong>, uK)<br />
16.00–16.30<br />
molecular mimicry in ankylosing sp<strong>on</strong>dylitis<br />
and rheumatoid arthritis<br />
Alan Ebringer (L<strong>on</strong>d<strong>on</strong>, UK)<br />
16.30–17.00<br />
polymyalgia rheumatica, blindness and anti-proteus<br />
antibodies<br />
Roland Pechlaner (Innsbruck, Austria)<br />
17.00–17.30<br />
* Vaccinati<strong>on</strong> and autoimmunity<br />
Nancy Agm<strong>on</strong>-Levin (Tel-Hashomer, Israel)<br />
16.30–18.30<br />
PRESENTATIONS OF YOUNG SCIENTISTS<br />
Co-Chairs: K. C<strong>on</strong>rad (Dresden, germany)<br />
u. sack (leipzig, germany)<br />
16.30–16.40<br />
* gender differences in oxidative stress and apoptosis<br />
of vascular cells induced by autoantibodies specific<br />
to rlip76<br />
Tania Colasanti (Rome, Italy)<br />
16.40-16.50<br />
* immortalized b cell lines from multiple sclerosis patients<br />
produce antibodies that bind an oligodendrocyte precursor<br />
cell line<br />
Judith Fraussen (Diepenbeek, Belgium)<br />
16.50–17.00<br />
* Analysis of autoantibody profiles in cerebrospinal fluid<br />
and serum of a relapsing-remitting ms patient with active<br />
disease using serological Antigen selecti<strong>on</strong><br />
Cindy Govarts (Diepenbeek, Belgium)<br />
10
Change language